AIM ImmunoTech (UK) Probability of Future Stock Price Finishing Over 14.49
| 0A4Y Stock | 0.23 0.02 9.52% |
AIM |
AIM ImmunoTech Target Price Odds to finish over 14.49
The tendency of AIM Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 14.49 or more in 90 days |
| 0.23 | 90 days | 14.49 | close to zero percent |
Based on a normal probability distribution, the odds of AIM ImmunoTech to move over 14.49 or more in 90 days from now is close to zero percent (This AIM ImmunoTech probability density function shows the probability of AIM Stock to fall within a particular range of prices over 90 days) . Probability of AIM ImmunoTech price to stay between its current price of 0.23 and 14.49 at the end of the 90-day period is about 82.06 .
Assuming the 90 days trading horizon AIM ImmunoTech has a beta of 0.75. This suggests as returns on the market go up, AIM ImmunoTech average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding AIM ImmunoTech will be expected to be much smaller as well. Additionally AIM ImmunoTech has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. AIM ImmunoTech Price Density |
| Price |
Predictive Modules for AIM ImmunoTech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AIM ImmunoTech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.AIM ImmunoTech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. AIM ImmunoTech is not an exception. The market had few large corrections towards the AIM ImmunoTech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold AIM ImmunoTech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of AIM ImmunoTech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.42 | |
β | Beta against Dow Jones | 0.75 | |
σ | Overall volatility | 0.03 | |
Ir | Information ratio | -0.09 |
AIM ImmunoTech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AIM ImmunoTech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AIM ImmunoTech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| AIM ImmunoTech generated a negative expected return over the last 90 days | |
| AIM ImmunoTech has some characteristics of a very speculative penny stock | |
| AIM ImmunoTech has high historical volatility and very poor performance | |
| AIM ImmunoTech has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 201 K. Net Loss for the year was (19.45 M) with loss before overhead, payroll, taxes, and interest of (715 K). | |
| Latest headline from news.google.com: AIM ImmunoTech says Glass Lewis recommends shareholders vote for nominees - TipRanks |
AIM ImmunoTech Technical Analysis
AIM ImmunoTech's future price can be derived by breaking down and analyzing its technical indicators over time. AIM Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of AIM ImmunoTech. In general, you should focus on analyzing AIM Stock price patterns and their correlations with different microeconomic environments and drivers.
AIM ImmunoTech Predictive Forecast Models
AIM ImmunoTech's time-series forecasting models is one of many AIM ImmunoTech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary AIM ImmunoTech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about AIM ImmunoTech
Checking the ongoing alerts about AIM ImmunoTech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for AIM ImmunoTech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| AIM ImmunoTech generated a negative expected return over the last 90 days | |
| AIM ImmunoTech has some characteristics of a very speculative penny stock | |
| AIM ImmunoTech has high historical volatility and very poor performance | |
| AIM ImmunoTech has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 201 K. Net Loss for the year was (19.45 M) with loss before overhead, payroll, taxes, and interest of (715 K). | |
| Latest headline from news.google.com: AIM ImmunoTech says Glass Lewis recommends shareholders vote for nominees - TipRanks |
Additional Tools for AIM Stock Analysis
When running AIM ImmunoTech's price analysis, check to measure AIM ImmunoTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AIM ImmunoTech is operating at the current time. Most of AIM ImmunoTech's value examination focuses on studying past and present price action to predict the probability of AIM ImmunoTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AIM ImmunoTech's price. Additionally, you may evaluate how the addition of AIM ImmunoTech to your portfolios can decrease your overall portfolio volatility.